QVT Financial (QVT) is a private investment firm located in New York, United States.
Since its establishment in 2003, the firm has specialized in hedge fund investments across a variety of markets globally, including the public equity and debt markets as well as alternative investment markets. QVT actively invests in structured finance, private placements, high yield, and distressed debt to construct its diverse investment portfolios.
The assets under QVT's management are overseen by its executive management team. With a focus on life sciences as part of its investment strategy, QVT is involved in sectors such as biotech/healthcare, technology, energy/shipping, financials/structured finance, and opportunistic/litigation investment areas.
The firm prides itself on being comprised of original thinkers from non-traditional backgrounds, providing a unique expertise and broad perspective towards investment.
This is demonstrated by its core areas of investment, which include Ophiucus for biotech/healthcare, Telescopium for technology, Argo for energy/shipping, UrsaMinor for financials/structured finance, and Libra for opportunistic/litigation. Their investment philosophy reflects a commitment to adaptation and change, as highlighted by a quote from Marcus Aurelius on their website, implying a dynamic approach to investment strategies that accord with the nature of an ever-evolving universe. QVT positions itself not just as a traditional investment firm but as a family office, where they aim to create smart and diverse investment opportunities guided by their extensive experience and distinctive non-linear thought process.





